Welcome to LookChem.com Sign In|Join Free

CAS

  • or

79200-57-0

Post Buying Request

79200-57-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79200-57-0 Usage

Description

(1R,2S,3R,4R)-2,3-DIHYDROXY-4-(HYDROXYMETHYL)-1-AMINOCYCLOPENTANE HYDROCHLORIDE is a complex organic compound with a cyclopentane ring structure, featuring four chiral centers and multiple hydroxyl and amino groups. (1R,2S,3R,4R)-2,3-DIHYDROXY-4-(HYDROXYMETHYL)-1-AMINOCYCLOPENTANE HYDROCHLORIDE is characterized by its unique stereochemistry and functional groups, which contribute to its potential applications in various fields.

Uses

Used in Pharmaceutical Industry:
(1R,2S,3R,4R)-2,3-DIHYDROXY-4-(HYDROXYMETHYL)-1-AMINOCYCLOPENTANE HYDROCHLORIDE is used as a reagent in the synthesis of pyridofuran substituted pyrimidine derivatives, which are known as hepatitis C virus (HCV) replication (replicase) inhibitors. These inhibitors play a crucial role in the development of antiviral drugs targeting the replication process of HCV, offering a potential treatment for hepatitis C.
In the synthesis process, the compound serves as a key intermediate, providing the necessary structural elements and functional groups for the formation of the desired pyridofuran substituted pyrimidine derivatives. The chiral centers and hydroxyl groups in the compound contribute to the selectivity and specificity of the synthetic reactions, ensuring the production of the desired enantiomer with the correct stereochemistry.
Overall, (1R,2S,3R,4R)-2,3-DIHYDROXY-4-(HYDROXYMETHYL)-1-AMINOCYCLOPENTANE HYDROCHLORIDE is a valuable compound in the pharmaceutical industry, particularly for the development of antiviral agents against hepatitis C virus. Its unique structural features and potential applications highlight the importance of chiral chemistry and stereoselective synthesis in drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 79200-57-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,2,0 and 0 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 79200-57:
(7*7)+(6*9)+(5*2)+(4*0)+(3*0)+(2*5)+(1*7)=130
130 % 10 = 0
So 79200-57-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO3/c7-4-1-3(2-8)5(9)6(4)10/h3-6,8-10H,1-2,7H2/p+1/t3-,4-,5-,6+/m1/s1

79200-57-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R,2S,3R,4R)-2,3-Dihydroxy-4-(hydroxymethyl)-1-aminocyclopentane hydrochloride

1.2 Other means of identification

Product number -
Other names (1R,2S,3R,5R)-3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:79200-57-0 SDS

79200-57-0Relevant articles and documents

RNAs Containing Carbocyclic Ribonucleotides

Akabane-Nakata, Masaaki,Chickering, Tyler,Egli, Martin,Harp, Joel M.,Manoharan, Muthiah,Matsuda, Shigeo,Schlegel, Mark K.

supporting information, (2022/01/12)

Toward the goal of evaluation of carbocyclic ribonucleoside-containing oligonucleotide therapeutics, we developed convenient, scalable syntheses of all four carbocyclic ribonucleotide phosphoramidites and the uridine solid-support building block. Crystall

CARBOCYCLIC NUCLEOSIDE DERIVATIVES AS INHIBITORS OF RNA-DEPENDENT RNA VIRAL POLYMERASE

-

Page 46-47, (2008/06/13)

The present invention provides carbocyclic nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such carbocyclic nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the carbocyclic nucleoside compounds of the present invention

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 79200-57-0